The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 03, 2017

Filed:

Mar. 05, 2014
Applicant:

University of Notre Dame Du Lac, Notre Dame, IN (US);

Inventors:

Mayland Chang, Granger, IN (US);

Shahriar Mobashery, Granger, IN (US);

Renee Bouley, Mishawaka, IN (US);

Assignee:

University of Notre Dame du Lac, Notre Dame, IN (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/517 (2006.01); C07D 239/91 (2006.01); C07D 401/06 (2006.01); C07D 405/06 (2006.01); C07D 471/04 (2006.01); A61K 45/06 (2006.01); A61K 31/43 (2006.01); A61K 31/431 (2006.01); A61K 31/545 (2006.01); A61K 31/546 (2006.01); A61K 31/7036 (2006.01); A61K 31/7048 (2006.01); A61K 31/519 (2006.01); A61K 31/5377 (2006.01); C07D 401/12 (2006.01);
U.S. Cl.
CPC ...
C07D 239/91 (2013.01); A61K 31/43 (2013.01); A61K 31/431 (2013.01); A61K 31/517 (2013.01); A61K 31/519 (2013.01); A61K 31/5377 (2013.01); A61K 31/545 (2013.01); A61K 31/546 (2013.01); A61K 31/7036 (2013.01); A61K 31/7048 (2013.01); A61K 45/06 (2013.01); C07D 401/06 (2013.01); C07D 401/12 (2013.01); C07D 405/06 (2013.01); C07D 471/04 (2013.01);
Abstract

A new class of antibiotics effective against methicillin-resistant(MRSA) is disclosed. Compounds of this class can impair cell-wall biosynthesis by binding to both the allosteric and the catalytic domains of penicillin-binding protein (PBP) 2a. This class of antibiotics holds promise in reversing obsolescence of staphylococcal PBPs as important targets for antibiotics. Embodiments of the invention thus provide novel antibacterial compounds that target penicillin-binding proteins and/or other important cellular targets. Methods for inhibiting the growth and/or replication of bacteria using the compounds described herein are also provided. Various embodiments exhibit activity against gram positive bacteria, including drug-resistant strains of


Find Patent Forward Citations

Loading…